Cargando…
A Case of Suspected Adverse Reactions to Sirolimus in the Treatment of Generalized Lymphatic Anomaly
Generalized lymphatic anomaly (GLA) is characterized by diffuse or multicentric proliferation of dilated lymphatic vessels resembling common lymphatic malformation, and thoracic lesions can be related to a poor prognosis. Sirolimus, an inhibitor of the mammalian target of rapamycin, is effective aga...
Autores principales: | Fujii, Takayuki, Shimono, Ryuichi, Tanaka, Aya, Katami, Hiroto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515074/ https://www.ncbi.nlm.nih.gov/pubmed/31183237 http://dx.doi.org/10.1155/2019/3101357 |
Ejemplares similares
-
Stapled versus hand-sewn intestinal anastomosis in pediatric patients: a systematic review and meta-analysis
por: Fujii, Takayuki, et al.
Publicado: (2021) -
Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
por: Treder, Natalia, et al.
Publicado: (2023) -
Neonatal Generalized Lymphatic Anomaly with Skin Involvement
por: Markovic-Sovtic, Gordana, et al.
Publicado: (2021) -
Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations
por: Curry, Steven, et al.
Publicado: (2019) -
The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies
por: Ozeki, Michio, et al.
Publicado: (2019)